Dermata Therapeutics (DRMA) Enterprise Value (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Enterprise Value of -$6.9 million for Q1 2026, up 28.4% year-over-year from -$5.4 million in Q1 2025, and up 7.67% quarter-over-quarter from -$7.5 million in Q4 2025.
Dermata Therapeutics (DRMA) Enterprise Value (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$6.9 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 28.4% year-over-year to -$6.9 million; the TTM figure through Mar 2026 stood at -$6.9 million (up 28.4% YoY), while the FY2025 annual figure was -$7.5 million, down 137.92% from the prior year.
- Enterprise Value for Q1 2026 stood at -$6.9 million, up from -$7.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$3.2 million in Q4 2024, with the low at -$10.6 million in Q2 2022.
- The 5-year median for Enterprise Value is -$6.9 million (2026), against an average of -$7.0 million.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value plunged 2387.79% in 2022, then surged 57.5% in 2024.
- Dermata Therapeutics' Enterprise Value stood at -$6.2 million in 2022, then fell by 19.18% to -$7.4 million in 2023, then soared by 57.5% to -$3.2 million in 2024, then sank by 137.92% to -$7.5 million in 2025, then rose by 7.67% to -$6.9 million in 2026.
- Business Quant data shows DRMA's Enterprise Value at -$6.9 million in Q1 2026, -$7.5 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 2.12 Bn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - | -6.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.95 Mn |
| Dec 31, 2025 | -7.52 Mn |
| Sep 30, 2025 | -4.70 Mn |
| Jun 30, 2025 | -6.48 Mn |
| Mar 31, 2025 | -9.70 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Sep 30, 2024 | -6.10 Mn |
| Jun 30, 2024 | -4.95 Mn |
| Mar 31, 2024 | -4.73 Mn |
| Dec 31, 2023 | -7.44 Mn |
| Sep 30, 2023 | -6.63 Mn |
| Jun 30, 2023 | -8.44 Mn |
| Mar 31, 2023 | -8.77 Mn |
| Dec 31, 2022 | -6.24 Mn |
| Sep 30, 2022 | -8.07 Mn |
| Jun 30, 2022 | -10.63 Mn |
| Mar 31, 2022 | -8.19 Mn |
| Dec 31, 2021 | -10.80 Mn |
| Sep 30, 2021 | -12.60 Mn |
| Jun 30, 2021 | -427,202.00 |